Aptorum Group Ltd Cl A (NQ: APM )

2.649 +0.059 (+2.28%)

Streaming Delayed Price Updated: 1:54 PM EDT, Oct 18, 2021 Add to My Watchlist

Price and Volume

Volume	52,932
Open	2.690
Bid (Size)	2.580 (5)
Ask (Size)	2.630 (2)
Prev. Close	2.590
Today's Range	2.551 - 2.690
52wk Range	2.000 - 4.940
Shares Outstanding	34,280,137
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Aptorum Group Limited Interview to Air on Bloomberg U.S.

October 15, 2021

Regulatory News:

Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2021

September 15, 2021

Regulatory News:

Performance

YTD	+6.81%	+6.81%
1 Month	+0.34%	+0.34%
3 Month	-11.40%	-11.40%
6 Month	-5.39%	-5.39%
1 Year	-4.37%	-4.37%

More News

Aptorum Group Limited Has Received IND Clearance From the US FDA to Initiate Clinical Trials for Repurposed Small Molecule Drug SACT-1 for the Treatment of Neuroblastoma

September 15, 2021

Aptorum Group Announces Further Positive Interim Results of the Phase 1 Clinical Trial of ALS-4 Targeting Staphylococcus aureus

July 12, 2021

Aptorum Group Interview to Air on Bloomberg Television U.S. on the RedChip Money Report

July 09, 2021

Aptorum Group CEO Subscribed Shares In The Company

May 26, 2021

3 Penny Stocks on Reddit Making Big Waves Right Now

May 24, 2021

Aptorum To Start Testing SACT-1 In Neuroblastoma Patients

September 15, 2021

Aptorum Shares Move Higher After Interim Data From Staphylococcus Aureus Candidate

July 12, 2021

12 Health Care Stocks Moving In Monday's Pre-Market Session

July 12, 2021

Aptorum Group Announces Positive Interim Phase I Clinical Trial Progress for ALS-4 Targeting Staphylococcus aureus and Positive Pre-IND Progress for SACT-1 Targeting Neuroblastoma

May 24, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.